Abbott Laboratories Stock Börse Stuttgart
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
08:36:52 2026-10-05 am EDT
|
5-day change | 1st Jan Change | ||
| 87.30 EUR | +0.97% |
|
-2.68% | -18.02% |
| 07:27am | Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating | MT |
| Oct. 02 | Weak Jobs Lead to Stronger Stocks |  |
| Market Cap | 169B 150B 140B 128B 241B 16,219B 243B 1,693B 656B 8,291B 633B 620B 26,610B | P/E 2026 * |
27.6x | P/E 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise Value | 193B 171B 160B 146B 275B 18,520B 277B 1,933B 749B 9,468B 723B 708B 30,385B | EV / Sales 2026 * |
3.84x | EV / Sales 2027 * | 3.48x |
| Free-Float |
86.16% | Yield 2026 * |
2.64% | Yield 2027 * | 2.81% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
Boerse Muenchen
| ABL | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Xetra
| ABL | Delayed | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 week | -2.68% | ||
| Current month | -0.98% | ||
| 1 month | -9.35% | ||
| 3 months | +3.89% | ||
| 6 months | -2.98% | ||
| Current year | -18.02% |
| 1 week | 85.02 |  | 89.44 |
| 1 month | 85.02 | | 95.72 |
| 3 years | 69.64 | | 134.1 |
| 5 years | 69.64 | | 134.1 |
| 10 years | 34 | | 134.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | -2.68% | -23.64% | -4.55% | 169B | |
| +0.84% | -3.74% | -27.56% | +1.93% | 169B | |
| -0.07% | -2.55% | -11.59% | +13.26% | 110B | |
| +0.90% | +1.13% | -25.66% | +3.47% | 106B | |
| +1.54% | -0.89% | -47.56% | -11.17% | 73.87B | |
| -0.24% | +0.69% | +2.08% | +69.19% | 58.98B | |
| +1.32% | +3.86% | +8.58% | +61.88% | 51.28B | |
| -0.71% | -3.82% | -8.68% | -31.93% | 48.16B | |
| +0.12% | -0.17% | -17.87% | +19.66% | 40.84B | |
| -1.01% | -1.45% | +27.31% | -2.67% | 32.21B | |
| Average | +0.05% | -0.86% | -12.46% | +11.91% | 76.69B | |
| Weighted average by Cap. | +0.05% | -1.30% | -18.45% | +8.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 44.61B 41.63B 37.95B 71.57B 4,826B 72.23B 504B 195B 2,467B 188B 184B 7,918B | 54.53B 48.45B 45.22B 41.22B 77.74B 5,242B 78.46B 547B 212B 2,680B 205B 200B 8,601B |
| Net income | 6.3B 5.6B 5.23B 4.76B 8.98B 606B 9.07B 63.25B 24.51B 310B 23.66B 23.15B 994B | 7.98B 7.09B 6.62B 6.03B 11.37B 767B 11.48B 80.06B 31.02B 392B 29.95B 29.3B 1,258B |
| Net Debt | 23.94B 21.27B 19.85B 18.09B 34.13B 2,301B 34.44B 240B 93.09B 1,176B 89.88B 87.93B 3,776B | 20.96B 18.62B 17.38B 15.84B 29.88B 2,015B 30.15B 210B 81.5B 1,030B 78.68B 76.98B 3,305B |
| Date | Price | Change |
|---|---|---|
| 26-10-05 | €87.48 | +1.18% |
| 26-10-02 | €86.46 | +0.61% |
| 26-10-01 | €85.94 | -1.58% |
| 26-09-30 | €87.32 | -1.78% |
| 26-09-29 | €88.90 | +0.16% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
Select your edition
All financial news and data tailored to specific country editions
